Are insiders buying KAPA stock?

Yes — 3 distinct insiders have bought KAPA (Kairos Pharma, LTD.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Nov 25, 2024.

How much KAPA stock have insiders bought?

Insiders have bought a combined $9.8K of KAPA across 3 open-market purchases, based on SEC Form 4 filings.

What is an insider cluster buy in KAPA?

A cluster buy is two or more distinct Kairos Pharma, LTD. insiders — officers, directors, or 10% owners — each buying KAPA on the open market within a rolling window. KAPA has 1 detected cluster buy to date.

Where does this KAPA insider trading data come from?

Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

KAPA insider buying

1 cluster buy

Kairos Pharma, LTD. · Healthcare

When two or more insiders at Kairos Pharma, LTD. buy KAPA in a qualifying detection window, the grouped purchases provide a starting point for further research. Below is every cluster we've detected in KAPA plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters

Distinct insiders

Total bought

$9.8K

Market cap

$8.3M

Detected clusters

Nov 20 – Nov 25, 2024
Detected Nov 25, 2024
Executive buyer3 insiders
Total bought
$9.8K
Market cap
$8.3M

All notable open-market buys in KAPA

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

Date	Insider	Shares	Price	Value	Filing
Nov 25, 2024	Murali Ramachandrancluster VP of Research and Development	200	$1.59	$318.0	SEC ↗
Nov 22, 2024	Samuelson Dougcluster Chief Financial Officer	2,500	$1.50	$3.8K	SEC ↗
Nov 20, 2024	Yu John Scluster Director, CEO and Chairman, 10% Owner	4,000	$1.44	$5.8K	SEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare →

KAPA insider buying — FAQ

Are insiders buying KAPA stock?: Yes — 3 distinct insiders have bought KAPA (Kairos Pharma, LTD.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Nov 25, 2024.
How much KAPA stock have insiders bought?: Insiders have bought a combined $9.8K of KAPA across 3 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in KAPA?: A cluster buy is two or more distinct Kairos Pharma, LTD. insiders — officers, directors, or 10% owners — each buying KAPA on the open market within a rolling window. KAPA has 1 detected cluster buy to date.
Where does this KAPA insider trading data come from?: Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in KAPA

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy KAPA within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding KAPA.